-
公开(公告)号：US20240342181A1
公开(公告)日：2024-10-17
申请号：US18299416
申请日：2023-04-12
Applicant: Xygenyx Inc.
Inventor： Alexy Goldstein
IPC: A61K31/52 , A61K9/00 , A61K31/20 , A61K31/201 , A61K31/205
CPC classification number: A61K31/52 , A61K9/0053 , A61K31/20 , A61K31/201 , A61K31/205
Abstract: A method and compositions of treatment for improving metabolic performance using supplementation, comprising the step of applying a supplement formulation to a human subject via a selected administration route, the supplement formulation comprising therapeutically effective amounts of a plurality of medium-chain triglycerides, a plurality of amino acids, and zeatin. The plurality of medium-chain triglycerides may comprise caprylic acid, and the plurality of amino acids may comprise carnitine which may be provided in the form of L-carnitine fumarate.
-
公开(公告)号：US20240238237A1
公开(公告)日：2024-07-18
申请号：US18289409
申请日：2022-05-04
Applicant: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
Inventor： Deborah J. Good
IPC: A61K31/201 , A61P1/14 , A61P3/04 , A61P5/24
CPC classification number: A61K31/201 , A61P1/14 , A61P3/04 , A61P5/24
Abstract: Described in certain example embodiments herein are methods of and compositions for treating a Snordl l6 deficiency disease or symptom thereof with conjugated linoleic acid (CLA) or a formulation thereof. In some embodiments, the Snordl l6 deficiency disease is Prader-Willi Syndrome. Described in certain example embodiments herein are methods of and compositions for treating Nhlh2 associated hypogonadism with CLA or a formulation thereof.
-
3.发明公开
公开(公告)号：US20240216456A1
公开(公告)日：2024-07-04
申请号：US18599039
申请日：2024-03-07
Applicant: Nodari RIZUN
Inventor： Nodari RIZUN
IPC: A61K36/47 , A61K31/047 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/352 , A61K36/185 , A61K36/48 , A61K36/61 , A61K36/752 , A61K36/76 , A61K36/835
CPC classification number: A61K36/47 , A61K31/047 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/352 , A61K36/185 , A61K36/48 , A61K36/61 , A61K36/752 , A61K36/76 , A61K36/835
Abstract: Compositions and methods of manufacturing mineral pitch resin compositions comprising at least one of a cannabinoid, a terpene, a terpenoid, an essential oil and a fatty acid are provided. Such mineral pitch resin compositions may be safely consumed orally, topically or otherwise, and have numerous health benefits.
-
公开(公告)号：US11992555B2
公开(公告)日：2024-05-28
申请号：US17448263
申请日：2021-09-21
Applicant: Infirst Healthcare Limited
Inventor： Robin M. Bannister , John Brew , Richard R. Reiley, III , Wilson Caparros Wanderley
IPC: A61K9/08 , A61K9/14 , A61K31/12 , A61K31/137 , A61K31/167 , A61K31/192 , A61K31/196 , A61K31/216 , A61K31/25 , A61K31/337 , A61K31/357 , A61K31/366 , A61K31/4178 , A61K31/4184 , A61K31/522 , A61K31/60 , A61K31/616 , A61K31/704 , A61K47/10 , A61K47/14 , A61K31/19 , A61K31/201
CPC classification number: A61K9/08 , A61K9/148 , A61K31/12 , A61K31/137 , A61K31/167 , A61K31/192 , A61K31/196 , A61K31/216 , A61K31/357 , A61K31/366 , A61K31/4178 , A61K31/4184 , A61K31/522 , A61K31/60 , A61K31/616 , A61K47/10 , A61K47/14 , A61K31/19 , A61K31/201 , A61K31/25 , A61K31/337 , A61K31/704
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号：US20240130994A1
公开(公告)日：2024-04-25
申请号：US18176094
申请日：2023-02-28
Applicant: i2O Therapeutics, Inc.
Inventor： Tyler Brown , Kelly IBSEN
IPC: A61K31/205 , A61K31/185 , A61K31/191 , A61K31/192 , A61K31/194 , A61K31/195 , A61K31/198 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/222 , A61K31/352 , A61K31/375 , A61K31/385 , A61K31/4015 , A61K31/575 , A61K33/42 , A61K38/17 , A61P3/10
CPC classification number: A61K31/205 , A61K31/185 , A61K31/191 , A61K31/192 , A61K31/194 , A61K31/195 , A61K31/198 , A61K31/20 , A61K31/201 , A61K31/202 , A61K31/222 , A61K31/352 , A61K31/375 , A61K31/385 , A61K31/4015 , A61K31/575 , A61K33/42 , A61K38/1796 , A61P3/10
Abstract: Disclosed herein are ionic liquids and deep eutectic liquids for the treatment of diabetes and related diseases including obesity and metabolic disorders.
-
公开(公告)号：US20240115535A1
公开(公告)日：2024-04-11
申请号：US18275972
申请日：2022-02-07
Applicant: Peter MILNER , Mikhail Sergeevich SHCHEPINOV , Retrotope, Inc.
Inventor： Peter Milner , Mikhail Sergeevich Shchepinov
IPC: A61K31/201 , A61P25/28 , G01N33/50 , G01N33/555
CPC classification number: A61K31/201 , A61P25/28 , G01N33/5044 , G01N33/555
Abstract: Disclosed are methods for inhibiting the progression of neurodegenerative disease. The methods include administering to a patient suffering from such a disease a composition comprising deuterated arachidonic acid or an ester thereof.
-
公开(公告)号：US11918617B2
公开(公告)日：2024-03-05
申请号：US16753512
申请日：2018-10-03
Applicant: NEILOS S.R.L.
Inventor： Umberto Di Maio
IPC: A61K36/537 , A61K9/00 , A61K31/12 , A61K31/201 , A61K31/385 , A61K36/30 , A61P25/02
CPC classification number: A61K36/537 , A61K9/0053 , A61K9/0056 , A61K31/12 , A61K31/201 , A61K31/385 , A61K36/30 , A61P25/02
Abstract: The present invention relates to a composition comprising α-lipoic acid, Salvia miltiorrhiza extract and Curcumin, optionally further comprising γ-linolenic acid or borage oil. Furthermore, the present invention relates to the use of such composition for treating neuropathies.
-
公开(公告)号：US11911425B2
公开(公告)日：2024-02-27
申请号：US17535804
申请日：2021-11-26
Applicant: IDUNN TECHNOLOGIES
Inventor： Eric Simard , Vladimir Titorenko
IPC: A61K36/00 , A61K36/16 , A61K36/84 , A61Q19/08 , A61K31/05 , A61K31/132 , A61K31/155 , A61K31/201 , A61K36/185 , A61K36/23 , A61K36/71 , A61K36/76 , A61K8/44 , A61K8/9771 , A61K8/9789 , A61P43/00 , A61K8/34 , A61K8/365 , A61K8/41 , A61K8/43
CPC classification number: A61K36/16 , A61K8/347 , A61K8/365 , A61K8/41 , A61K8/43 , A61K8/44 , A61K8/9771 , A61K8/9789 , A61K31/05 , A61K31/132 , A61K31/155 , A61K31/201 , A61K36/185 , A61K36/23 , A61K36/71 , A61K36/76 , A61K36/84 , A61P43/00 , A61Q19/08 , A61K2800/5922 , A61K2800/78 , A61K36/16 , A61K2300/00 , A61K36/23 , A61K2300/00 , A61K36/76 , A61K2300/00 , A61K36/185 , A61K2300/00 , A61K36/71 , A61K2300/00 , A61K36/84 , A61K2300/00 , A61K31/05 , A61K2300/00 , A61K31/155 , A61K2300/00 , A61K31/201 , A61K2300/00 , A61K31/132 , A61K2300/00
Abstract: The present description relates to an anti-aging composition comprising at least one plant extract. The composition can comprise at least two different anti-aging agents, wherein one the anti-aging agent is a plant extract. The combination of two anti-aging agents has a superior effect on regulating longevity compared to the use of one anti-aging agent. The plant extract is preferably selected from the group consisting of a Black cohosh extract, a Valerian extract, a Ginkgo biloba extract, a Celery seed extract, a White willow extract and a Passion flower extract.
-
公开(公告)号：US11890294B2
公开(公告)日：2024-02-06
申请号：US17500604
申请日：2021-10-13
Applicant: HYPHENS PHARMA PTE. LTD.
Inventor： Kevin Hammond , Adrian Davis
IPC: A61K31/7032 , A61K9/00 , A61K31/164 , A61K31/191 , A61K31/201 , A61K31/365 , A61K31/575 , A61K33/30 , A61K47/10 , A61K47/14 , A61K9/06
CPC classification number: A61K31/7032 , A61K9/0014 , A61K31/164 , A61K31/191 , A61K31/201 , A61K31/365 , A61K31/575 , A61K33/30 , A61K47/10 , A61K47/14 , A61K9/06
Abstract: The present invention provides a composition for topical administration of a polyhydroxy acid, such as lactobionate and especially zinc lactobionate, and low pH to an external body surface such as skin. The composition is designed to be highly effective in delivering low pH and zinc lactobionate across the layers of the skin to more effectively treat and prevent skin conditions involving a defective skin barrier such as eczema and severe dry skin.
-
公开(公告)号：US20240025870A1
公开(公告)日：2024-01-25
申请号：US18375745
申请日：2023-10-02
Applicant: Synaptogenix, Inc.
Inventor： Thomas J. NELSON , Daniel L. ALKON
IPC: C07D303/42 , A61K31/045 , A61K31/23 , A61K31/231 , A61K31/335 , A61P25/00 , A61P25/28 , A61K31/201 , C07C31/13 , C07C31/133 , C07C53/134 , C07C69/608 , C07D303/40 , C12N9/12
CPC classification number: C07D303/42 , A61K31/045 , A61K31/23 , A61K31/231 , A61K31/335 , A61P25/00 , A61P25/28 , A61K31/201 , C07C31/13 , C07C31/1333 , C07C53/134 , C07C69/608 , C07D303/40 , C12N9/12 , C12Y207/11013
Abstract: The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimers disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.
